Drug intelligence / Profile preview

Effaclar Duo+M

Development stage
Unknown
Lead developer
La Roche-Posay
Modality
Small Molecules
Administration
Topical
01

Overview

Effaclar Duo+M is a triple-action corrective treatment for oily and acne-prone skin developed by La Roche-Posay. It is formulated to target severe and recurring imperfections, blackheads, and post-acne marks. The key innovation in this version is the inclusion of **Phylobioma**, an active ingredient derived from green science that specifically targets the *Cutibacterium acnes* phylotype IA1 to help rebalance the skin's microbiome and reduce biofilm formation. Other active components include **Niacinamide** for soothing and reducing redness, **Salicylic Acid** and **LHA** for exfoliation and pore-unclogging, **Procerad** (a patented ceramide) to prevent red or brown post-inflammatory hyperpigmentation, and **Zinc PCA** to regulate sebum production. It is clinically indicated for the management of acne-prone skin and the prevention of blemish recurrence.

Brand names
Effaclar Duo+M
Other names
Effaclar Duo+M Anti-Imperfections Moisturizer

Beyond the preview

Go deeper on Effaclar Duo+M.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Effaclar Duo+M.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call